Endocrinology, Diabetes & Metabolism Doctors in Camden, ME - Medicare Status, Address, Contact

1 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 1

Dr. Roger Scott Rittmaster, M.D.
Internal Medicine - Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 42 William Glen Dr, Camden, ME 04843
Phone: 207-470-0445

News Archive

Michigan Tech develops three new open-source tools in response to COVID-19

Michigan Tech's Open Sustainability Technology Lab developed three new open-source tools in response to COVID-19: a high-temperature 3D printer, a firefighter PAPR mask and a printable, emergency-use ventilator.

Researchers develop new diagnostic approach to fight against Chagas disease

Chagas disease is one of the most deadly parasitic diseases in the world. It affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year. A reliable and rapid diagnosis is the key in the battle against infection but until now, this has been next to impossible.

Glide Pharma to utilize $4.3M funding for progressing octreotide programme into clinical development

Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.

Prescription drug cost increases continuing to outpace inflation

A new report released today by AARP found the annual rate of manufacturers' price increases for the 197 brand name prescription drugs most commonly used by older Americans more than tripled the rate of inflation over the 12-month period ending on September 30, 2004.

Sclerosis patients treated with HSCT experience better long-term event-free survival

Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in the June 25 issue of JAMA.

Endocrinology, Diabetes & Metabolism Doctors in Camden, ME Accepting Medicare